Cargando…
Reduction in the weight, gained due to dolutegravir, following switch to bictegravir
BACKGROUND: HIV-infected individuals can live with the virus for decades, and the physicians have to review the long-term health implications of weight gain as they would for any other patient. Although the integrase strand transfer inhibitors (INSTIs) class of drugs are one of the most popular regi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282705/ https://www.ncbi.nlm.nih.gov/pubmed/35846543 http://dx.doi.org/10.4103/ijstd.ijstd_73_21 |